clofarabine
Showing 26 - 50 of 172
Autoimmune Disease, Crohn Disease, Inflammatory Disorder Trial in Los Angeles (Computed Tomography, Fluorine F 18 Clofarabine,
Completed
- Autoimmune Disease
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 2, 2020
18F-Clofarabine PET/CT in Imaging Cancer Patients Before and
Terminated
- Malignant Neoplasm
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Aug 10, 2020
Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,
Active, not recruiting
- Acute Lymphoid Leukemia (ALL)
- +5 more
- Hyperfractionated total body irradiation
- +9 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +10 more
- Bortezomib
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Acute Lymphoblastic Leukemia Trial in La Jolla, San Diego (Alemtuzumab, Clofarabine)
Terminated
- Acute Lymphoblastic Leukemia
- Alemtuzumab
- Clofarabine
-
La Jolla, California
- +2 more
Jul 29, 2020
High Risk Myeloid Malignancies, Cord Blood Transplant Trial in New York (ECT-001-CB (UM171-Expanded Cord Blood Transplant))
Recruiting
- High Risk Myeloid Malignancies
- Cord Blood Transplant
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 12, 2022
Stem Cell Transplantation, Leukemia, Lymphoma Trial in Houston (Thiotepa, Clofarabine, Busulfan)
Completed
- Stem Cell Transplantation
- +2 more
- Thiotepa
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 25, 2020
Non-Malignant Hematologic Disorders Trial in New York (Melphalan, Thiotepa, Clofarabine)
Terminated
- Non-Malignant Hematologic Disorders
- Melphalan
- +5 more
-
New York, New YorkMemorial SloanKettering Cancer Center
Mar 1, 2021
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,
Completed
- Acute Lymphoblastic Leukemia
- +3 more
- total body irradiation
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 17, 2021
Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)
Completed
- Leukemia
- Clofarabine
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 17, 2020
Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Stem Cell Transplantation
- busulfan, cyclophosphamide and melphalan, BuCyMel
- clofarabine, fludarabine and busulfan, CloFluBu
-
Brussels, Belgium
- +16 more
Jul 25, 2022
Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco
Terminated
- Myeloid Malignancy
- +5 more
- Alemtuzumab
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 25, 2020
Acute Myeloid Leukemia Trial in Aurora, New Orleans, Seattle (procedure, drug, other, radiation)
Completed
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Aurora, Colorado
- +3 more
Apr 3, 2020
Lymphoma Trial in Portland (biological, drug, genetic, other)
Terminated
- Lymphoma
- rituximab
- +7 more
-
Portland, OregonKnight Cancer Institute at Oregon Health and Science University
Nov 15, 2019
Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia Trial in Columbus, Madison, Milwaukee (Clofarabine, Cyclophosphamide,
Terminated
- Leukemia, Acute Lymphoblastic
- Acute Myeloid Leukemia
- Clofarabine
- +2 more
-
Columbus, Ohio
- +3 more
Feb 18, 2020
Myeldysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, Bone Marrow Diseases Trial run by the NHLBI (Clofarabine,
Completed
- Myeldysplastic Syndrome (MDS)
- +4 more
- Clofarabine
- Lenalidomide
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
PET Imaging of the Immune System Using Analog Probes
Completed
- Malignant Melanoma
- [18F] CFA
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Oct 8, 2021
Leukemia Trial in Hershey (Clofarabine, Mitoxantrone, Etoposide)
Terminated
- Leukemia
- Clofarabine
- +2 more
-
Hershey, PennsylvaniaPenn State Hershey Cancer Institute
Jul 22, 2019
Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)
Terminated
- Acute Myelogenous Leukemia
- Plerixafor
- Clofarabine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 19, 2019
Leukemia Trial in Houston (Decitabine, Idarubicin, Cytarabine)
Completed
- Leukemia
- Decitabine
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 28, 2019
Metastatic Solid Tumor Trial (TAC01-CLDN18.2)
Not yet recruiting
- Metastatic Solid Tumor
- TAC01-CLDN18.2
- (no location specified)
May 8, 2023
Myelodysplastic Syndrome, Leukemia Trial in Houston (procedure, drug, other, radiation)
Completed
- Myelodysplastic Syndrome
- Leukemia
- Cord Blood Infusion
- +11 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 27, 2020
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia
Active, not recruiting
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +16 more
- clofarabine
- +7 more
-
Birmingham, Alabama
- +268 more
Feb 23, 2021